3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase 3
2
Phase 1
2
Phase NA
1
Phase EARLY_PHASE1
1
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Ovarian Neoplasms
3
Fallopian Tube Neoplasms
3
Small Cell Lung Carcinoma
2
Retinoblastoma
1
Cystadenocarcinoma, Serous
1
Carcinoma, Ovarian Epithelial
1
Interventions
Vincristine
1
Topotecan
1
Platinum Compounds
1
Melphalan
1
Hyperthermia, Induced
1
Etoposide
1
Drug Therapy
1
Cryotherapy
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Retinoblastoma
×
Topotecan
×
Clear all
NCT04681417
2025-11-28
RETINO 2018
Institut Curie
Phase 2/3
Recruiting
225 enrolled